These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12694400)

  • 41. Adenosine A2 receptor-mediated excitatory actions on the nervous system.
    Sebastião AM; Ribeiro JA
    Prog Neurobiol; 1996 Feb; 48(3):167-89. PubMed ID: 8735876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular and Structural Insight into Adenosine A
    Karati D; Mukherjee S; Roy S
    Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second messenger pathways in the modulation of neurotransmitter release.
    Majewski HK; Musgrave IF
    Aust N Z J Med; 1995 Dec; 25(6):817-21. PubMed ID: 8770358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulators of nucleoside metabolism in the therapy of brain diseases.
    Boison D
    Curr Top Med Chem; 2011; 11(8):1068-86. PubMed ID: 21401494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.
    Fredholm BB
    Pharmacol Toxicol; 1995 Feb; 76(2):93-101. PubMed ID: 7746802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purinoceptors modulating the release of noradrenaline.
    von Kügelgen I
    J Auton Pharmacol; 1994 Feb; 14(1):11-2. PubMed ID: 8150807
    [No Abstract]   [Full Text] [Related]  

  • 47. Age-related changes in adrenergic neuroeffector transmission.
    Docherty JR
    Auton Neurosci; 2002 Feb; 96(1):8-12. PubMed ID: 11911505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential role of adenosine antagonist therapy in pathological tremor disorders.
    Mally J; Stone TW
    Pharmacol Ther; 1996; 72(3):243-50. PubMed ID: 9364577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and function of adenosine receptor heteromers.
    Franco R; Cordomí A; Llinas Del Torrent C; Lillo A; Serrano-Marín J; Navarro G; Pardo L
    Cell Mol Life Sci; 2021 Apr; 78(8):3957-3968. PubMed ID: 33580270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of purinergic receptors in the Alzheimer's disease.
    Cieślak M; Wojtczak A
    Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presynaptic P2 receptors?
    Stone TW; O'Kane EM; Nikbakht MR; Ross FM
    J Auton Nerv Syst; 2000 Jul; 81(1-3):244-8. PubMed ID: 10869728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.
    Takahashi RN; Pamplona FA; Prediger RD
    Front Biosci; 2008 Jan; 13():2614-32. PubMed ID: 17981738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases.
    Gaudry M; Vairo D; Marlinge M; Gaubert M; Guiol C; Mottola G; Gariboldi V; Deharo P; Sadrin S; Maixent JM; Fenouillet E; Ruf J; Guieu R; Paganelli F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Translational Experimental Basis of Indirect Adenosine Receptor Agonist Stimulation for Bone Regeneration: A Review.
    Ehlen QT; Mirsky NA; Slavin BV; Parra M; Nayak VV; Cronstein B; Witek L; Coelho PG
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A glance at adenosine receptors: novel target for antitumor therapy.
    Merighi S; Mirandola P; Varani K; Gessi S; Leung E; Baraldi PG; Tabrizi MA; Borea PA
    Pharmacol Ther; 2003 Oct; 100(1):31-48. PubMed ID: 14550503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases.
    Thiel M; Caldwell CC; Sitkovsky MV
    Microbes Infect; 2003 May; 5(6):515-26. PubMed ID: 12758281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of adenosine receptors in mood and anxiety disorders.
    van Calker D; Biber K; Domschke K; Serchov T
    J Neurochem; 2019 Oct; 151(1):11-27. PubMed ID: 31361031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenosine receptors as drug targets--what are the challenges?
    Chen JF; Eltzschig HK; Fredholm BB
    Nat Rev Drug Discov; 2013 Apr; 12(4):265-86. PubMed ID: 23535933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Adenosine Receptors in Neurological Diseases.
    Atif M; Alsrhani A; Naz F; Imran M; Imran M; Ullah MI; Alameen AAM; Gondal TA; Raza Q
    Cell Reprogram; 2021 Apr; 23(2):57-72. PubMed ID: 33861641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic potential of adenosine analogues and conjugates.
    Samsel M; Dzierzbicka K
    Pharmacol Rep; 2011; 63(3):601-17. PubMed ID: 21857072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.